ArticleExperimental and therapeutic medicine2014

Sorafenib-based therapy in HER2-negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials.

Qi-Xing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.